Working in partnership, is a powerful way to boost pipelines and support preclinical and clinical research and development.The challenge is finding the right partner and the right product or project.
As drugs, devices and other healthcare products become more innovative and complex, and as development costs increase, working collaboratively becomes more important.
The Asia Pacific region is slated to record the highest growth rate in healthcare IT, with organizations digitizing in order to ensure patient safety and streamlining of workflow systems.
The angiogenesis inhibitors and immune checkpoint inhibitors are the directions of main liver cancer drugs in development, and the drug combinations are also in development.